Standard BioToolsvsUnitedHealth

LAB and UNH stock compared: price, dividend, valuation and results, from SEC filings.

LAB

Standard BioTools Inc.

$0.54

Value $210M

-12.90%
LAB's page

UNH

UnitedHealth Group Incorporated

$389.68

Value $354B

-5.42%
UNH's page

Standard BioTools (LAB) has a market value of $210M and UnitedHealth (UNH) $354B. Over the last year, with dividends, LAB moved -56.5% and UNH +24.3%. Dividend yield: LAB none, UNH 2.32%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    LAB$210M

    UNH$354B

    UNH is 1,681 times LAB

  • Revenue, 12 months

    LAB$84M

    UNH$450B

    UNH is 5,326 times LAB

  • Net income, 12 months

    LAB$133M

    UNH$15.9B

    UNH is 119 times LAB

  • Operating margin

    LAB-97.5%

    UNH5.3%

    102.8 points apart

  • ROIC

    LAB-13.1%

    UNH11.3%

    24.4 points apart

  • P/E

    LAB–

    UNH22.3

  • Dividend yield

    LAB0.0%

    UNH2.3%

    2.3 points apart

  • 5-year return

    LAB-88.9%

    UNH-5.1%

    83.8 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

LAB-88.9%

UNH-5.1%

5010020222023202420252026
Returns by period
PeriodLABWith dividendsUNHWith dividends
1 year since November 14, 2025-56.5%Price -56.5%+24.3%Price +21.1%
3 years since November 17, 2023-75.9%-37.8% a yearPrice -75.9%-22.6%-8.2% a yearPrice -27.3%
5 years since November 16, 2021-88.9%-35.6% a yearPrice -88.9%-5.1%-1.0% a yearPrice -13.3%
10 years since November 17, 2016-91.0%-21.4% a yearPrice -91.0%+205.2%+11.8% a yearPrice +158.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

LABStandard BioToolsUNHUnitedHealth

Valuation

LABUNH
Valuation
Price$0.54$389.68
Market value$210M$354B
Enterprise value (EV)–$399B
P/E–22.3
P/E, 5-year median–25.0
P/B0.43.4
EV/EBIT–16.7
Free cash flow yield–6.5%

Results and growth

LABUNH
Results and growth
Revenue, 12 months$84M$450B
Net income, 12 months$133M$15.9B
Free cash flow, 12 months-$66M$22.8B
Earnings per share, 12 months$0.34$17.52
Revenue growth, year on year-6.2%11.8%
Revenue growth a year, past-9.2%over 5 years+11.7%over 5 years
EPS growth a year, past–-3.8%over 5 years

Margins and returns on capital

LABUNH
Margins and returns on capital
Gross margin52.2%88.3%
Operating margin-97.5%5.3%
Net margin157.6%3.5%
ROIC-13.1%11.3%
ROE26.8%15.5%

Balance sheet

LABUNH
Balance sheet
Cash$461M$28.5B
Total debt$27M$74.3B
Net debt / EBITDA–1.6
Interest cover–6.2×

Dividends and buybacks

LABUNH
Dividends and buybacks
Dividend yield–2.3%
Dividend per share, 12 months–$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield–1.6%
Shareholder yield–3.9%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: LAB or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, Standard BioTools or UnitedHealth?

By market value, UnitedHealth ($354B) is about 1,681.1 times Standard BioTools ($210M), at today's prices.

How did LAB and UNH stock do over the last 10 years?

Since November 17, 2016, LAB's price moved -91.0% and UNH's +158.5%. With dividends: LAB -91.0% (-21.4% a year), UNH +205.2% (+11.8% a year). Past returns do not predict future ones.

Which pays the higher dividend, LAB or UNH?

The dividend yield at today's price is none for Standard BioTools and 2.32% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.

Which has the higher profit margins, Standard BioTools or UnitedHealth?

Over the last twelve months, the net margin was 157.6% for Standard BioTools and 3.5% for UnitedHealth, and the operating margin -97.5% and 5.3%. Revenue was $84M and $450B.

Which is the better investment, Standard BioTools or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.